Prevalence of Asthma in Multiple Sclerosis: A United States Population-based Study
Overview
Authors
Affiliations
Background: Multiple sclerosis (MS) and asthma are complex multifactorial diseases which adversely impact daily functioning. However, the prevalence of asthma in those with MS is not clear. The objective of this study is to characterize the prevalence of asthma in those with MS, with considerations for age, gender, and race.
Methods: We conducted a U.S. population-based, cross-sectional study of electronic health record information for 56.6 million Americans available in the IBM® Explorys EPM: Explore database. We evaluated the prevalence of asthma in MS (N = 141,880) and non-MS (N = 56,416,790) cohorts, stratifying by age, gender, and race (All, White Americans, and African Americans).
Results: The prevalence of asthma was significantly greater among those with MS than the general population across age, gender, and racial subpopulations. Adjusting for age and gender, asthma was three times more common in MS. In the MS cohort, the prevalence of asthma had a U-shaped distribution with respect to age, with the greatest asthma prevalence among the young and the elderly (> 20% prevalence among those <30 or ≥80 years; prevalence range: 15 to 30%); this significantly differed from the fairly uniform distribution observed in the non-MS cohort (prevalence range: 4 to 9%). These patterns were relatively consistent when stratifying by gender and race.
Conclusion: Asthma is significantly more common in those with MS than in the general population - particularly in the young and elderly - irrespective of gender and race. The results add to the growing MS comorbidity literature, and emphasizes the need for comorbidity management as a part of comprehensive MS patient care.
Leptin and Leptin Signaling in Multiple Sclerosis: A Narrative Review.
Flores-Cordero J, Aranaz-Murillo A, Vilarino-Garcia T, Perez-Perez A, Izquierdo G, Flores-Campos R Neuromolecular Med. 2025; 27(1):19.
PMID: 40019662 PMC: 11870953. DOI: 10.1007/s12017-025-08842-4.
Gralha de Caneda M, Batista Oliveira Silva C, Aragon de Vecino M Int J MS Care. 2024; 26(Q3):239-246.
PMID: 39246686 PMC: 11377689. DOI: 10.7224/1537-2073.2023-103.
Sahu B, Nookala S, Floden A, Ambhore N, Sathish V, Klug M Brain Behav Immun. 2024; 121:365-383.
PMID: 39084541 PMC: 11442016. DOI: 10.1016/j.bbi.2024.07.038.
The lung-brain axis in multiple sclerosis: Mechanistic insights and future directions.
Kular L Brain Behav Immun Health. 2024; 38:100787.
PMID: 38737964 PMC: 11087231. DOI: 10.1016/j.bbih.2024.100787.
Hsieh S, Shultz J, Briggs F, Espinel Z, Shapiro L Int J MS Care. 2023; 25(4):152-156.
PMID: 37469332 PMC: 10353692. DOI: 10.7224/1537-2073.2022-032.